Median Technologies SA Company
Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, France.
Total Funding:
135662978
Funding Status:
IPO
Employee Number:
101-250
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2023-07-11
Investors Number:
6
Founded Date:
2002-01-01
Industry:
Analytical Algoritms